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Purpose: In 90Y microsphere radioembolization (RE), accurate post-therapy imaging-based
dosimetry is important for establishing absorbed dose versus outcome relationships for develop-
ing future treatment planning strategies. Additionally, accurately assessing microsphere distribu-
tions is important because of concerns for unexpected activity deposition outside the liver.
Quantitative 90Y imaging by either SPECT or PET is challenging. In 90Y SPECT model based
methods are necessary for scatter correction because energy window-based methods are not
feasible with the continuous bremsstrahlung energy spectrum. The objective of this work was
to implement and evaluate a scatter estimation method for accurate 90Y bremsstrahlung
SPECT/CT imaging.
Methods: Since a fully Monte Carlo (MC) approach to 90Y SPECT reconstruction is computa-
tionally very demanding, in the present study the scatter estimate generated by a MC simulator
was combined with an analytical projector in the 3D OS-EM reconstruction model. A single
window (105 to 195-keV) was used for both the acquisition and the projector modeling. A
liver/lung torso phantom with intrahepatic lesions and low-uptake extrahepatic objects was
imaged to evaluate SPECT/CT reconstruction without and with scatter correction. Clinical
application was demonstrated by applying the reconstruction approach to five patients treated
with RE to determine lesion and normal liver activity concentrations using a (liver) relative
calibration.
Results: There was convergence of the scatter estimate after just two updates, greatly reducing
computational requirements. In the phantom study, compared with reconstruction without scatter
correction, with MC scatter modeling there was substantial improvement in activity recovery in
intrahepatic lesions (from > 55% to > 86%), normal liver (from 113% to 104%), and lungs
(from 227% to 104%) with only a small degradation in noise (13% vs. 17%). Similarly, with
scatter modeling contrast improved substantially both visually and in terms of a detectability
index, which was especially relevant for the low uptake extrahepatic objects. The trends
observed for the phantom were also seen in the patient studies where lesion activity concentra-
tions and lesion-to-liver concentration ratios were lower for SPECT without scatter correction
compared with reconstruction with just two MC scatter updates: in eleven lesions the mean
uptake was 4.9 vs. 7.1 MBq/mL (P = 0.0547), the mean normal liver uptake was 1.6 vs.
1.5 MBq/mL (P = 0.056) and the mean lesion-to-liver uptake ratio was 2.7 vs. 4.3 (P = 0.0402)
for reconstruction without and with scatter correction respectively.
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Conclusions: Quantitative accuracy of 90Y bremsstrahlung imaging can be substantially improved
with MC scatter modeling without significant degradation in image noise or intensive computational
requirements. © 2017 American Association of Physicists in Medicine [https://doi.org/10.1002/
mp.12597]
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1. INTRODUCTION
Internal emitter therapy with 90Y is associated with promis-
ing clinical results in radioembolization (RE) for liver malig-
nancies1 and radioimmunotherapy (RIT) for non-Hodgkin’s
lymphoma (NHL).2 In addition, there are several ongoing
clinical trials for 90Y labeled agents including 90Y DOTA-
TOC peptide receptor radionuclide therapy for neuroen-
docrine tumors and 90Y-clivatuzumab tetraxetan RIT for
pancreatic cancer.3 These novel therapeutic applications have
sparked growing interest in quantitative imaging of 90Y,4–8 an
almost pure beta emitter (average energy, 0.94 MeV; maxi-
mum energy, 2.3 MeV; mean tissue penetration, 2.5 mm;
half-life, 64 h).9 In RE, accurate post-therapy activity quan-
tification is important for establishing lesion absorbed dose
vs. response and normal liver absorbed dose vs. toxicity rela-
tionships for future treatment planning. In addition, accurate
assessment of the post-therapy microsphere distribution is
important for safety because of the potential for unexpected
deposition outside the liver.
The lack of gamma photons simplifies radioprotection of
nontarget organs and other personnel, but complicates quanti-
tative imaging of 90Y; it involves SPECT via bremsstrahlung
photons produced by the betas4 or PET via a very low abun-
dance positron in the presence of bremsstrahlung.7 PET has
the advantage of superior resolution that can lead to better
quantification of smaller lesions, but a disadvantage is the
high noise associated with low (true) count-rates in the pres-
ence of high random fractions.10 In addition, the fact that
SPECT imaging is more widely accessible and cost effective
than PET makes it a viable contender for quantitative 90Y
imaging. However, standard SPECT reconstruction algo-
rithms available in the clinic are designed for gamma-rays
with well-defined energies and not for bremsstrahlung pho-
tons that have a continuous energy spectrum. Those recon-
struction methods are suboptimal for 90Y primarily because
of penetration/downscatter from photons extending to
2.3 MeV, and the infeasibility of using window-based scatter
correction with a continuous spectrum. In addition, less than
3% of 90Y beta interactions in tissue yield bremsstrahlung
photons > 50-keV,11,12 so low count-rates are encountered
when imaging under low uptake conditions. To overcome
some of these limitations Rong et al.5 and Elschot et al.6
developed specialized 90Y SPECT reconstruction methods.
For modeling scatter effects Rong et al. used a precalculated
scatter kernel approach while Elschot et al. used a fast fully
MC forward projector for ‘on the fly’ estimation. MC scatter
estimation is generally accepted to be more accurate for
regions with heterogeneous attenuation and for multiorder
scatter than the scatter kernel approach. However, a fully MC
approach to 90Y SPECT reconstruction is computationally
very demanding. Furthermore, a fully MC forward projector
would be prohibitively large to store as a matrix for 3D recon-
struction13 so one must use an unmatched back-projector,
causing convergence issues with some iterative algorithms.
Hence, in the present study we use the approach of using
MC to generate only the scatter estimate. Following,14 during
each iteration we add this scatter estimate to the forward pro-
jection of the current activity estimate formed using an ana-
lytical projector based on a system matrix that accounts for
attenuation and collimator response. Previously, our group
demonstrated this approach in 131I SPECT, where initial itera-
tions used a triple energy window scatter correction, and later
iterations used MC-based scatter estimates.15 Moore et al.
used a similar approach for 111In SPECT.16 Correcting brems-
strahlung SPECT is more challenging because the scatter
contribution is substantially higher and because window-
based correction is infeasible even for the initial iterations.
Because the scatter estimate may not need to be updated at
each iteration, as we demonstrated for 131I,15 minimizing MC
computation time is less critical with our approach using an
analytical projector than with a fully MC projector. Thus, our
MC simulations model detailed photon transport in the object
and camera, including the collimator, avoiding approxima-
tions. In addition, because the MC estimated scatter is not
part of the system matrix, we use a back-projector that is the
exact transpose of the system matrix, thereby avoiding the
‘mismatch’ that is present in methods that include scatter in
the forward projector matrix but not in the backprojector due
to the demands on memory and computation.17
Multiwindow modeling approach to bremsstrahlung recon-
struction use a wider acquisition window while maintaining an
accurate measurement model. Multiwindow modeling was
combined with a single wide acquisition window in the work
of Rong et al. (100–500-keV)5 and Elschot et al. (50–250-
keV)6 while we investigated combining multiwindow acquisi-
tion with multiwindow reconstruction for two energy ranges
(105–285-keV and 100–700-keV).18 While a wider range of
the bremsstrahlung energy spectrum is necessary for low
count-rate applications, such as imaging following 90Y RIT, a
single-window approach with a narrower energy range is suffi-
cient for imaging following RE where there is high focal
uptake in the liver. This is particularly true in RE with glass
microspheres, where typically 2–4 GBq are infused to the
liver. Thus, in the present study, we use a single, relatively nar-
row acquisition/reconstruction window (105 to 195-keV) that
allows the use of a single-energy attenuation map, scatter map
and collimator detector response (CDR) function.
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This paper compares the proposed single-window 90Y
SPECT reconstruction using MC scatter estimation with
reconstruction without scatter correction both qualitatively
and quantitatively using metrics such as activity recovery,
noise and visibility in a phantom study. Finally to demon-
strate clinical applicability, our reconstruction approach is
applied to five postradioembolization SPECT/CT patient
studies to determine lesion activity concentrations and lesion-
to-liver uptake ratios.
2. METHOD
2.A. Measurement model
We used a single relatively narrow energy window for
both the acquisition and for the projector modeling with the
following statistical model:
Yi  Poisson
XJ
j¼1aijxj
 
þ si
n o
; (1)
where Yi denotes the number of counts measured in the ith
detector pixel, aij denotes elements of the system matrix A
that models effects of depth-dependent attenuation and colli-
mator/detector blur for a photon leaving the jth voxel toward
the ith detector pixel, si denotes the scatter ‘contamination’
component for the ith detector pixel and x ¼ x1; . . .; xJð Þ
denotes the vector of unknown 90Y activity voxel values.
We use a fast rotate-attenuate-convolve-sum approach to
compute the forward projection multiplication Ax19 at each
iteration, to which we add the scatter estimate in the
denominator of the expectation-maximization (EM) algo-
rithm.14
The above model combines a system matrix A with
scatter si estimated by MC. This approach allows us to
use an exact matrix transpose AT as the back-projector that
considers only attenuation and detector blur (not scatter),
matching the forward projector. In our formulation, the
first term of Eq. (1) consists of full-energy (primary)
events, which are defined as events that originate with a
bremsstrahlung photon energy within the energy range of
the acquisition window and deposit their total energy in
the detector crystal (Table I). The second term consists of
scatter contamination events (estimated by MC), including
scatter events that originate with emission energies within
the acquisition window as well as downscatter events that
originate with emission energies outside the window
(Table I).
2.A.1. SIMIND scatter estimate
We use the SIMIND MC code20 to estimate the scatter
contamination component si in Eq. (1). The input to SIMIND
is the current reconstruction of the 90Y distribution, which
describes the beta decay spatial distribution. As described
previously,4,5 because SIMIND does not include electron
transport, a precalculated spectrum of bremsstrahlung pho-
tons12,21 is used to sample the photon emission energy and a
distance histogram is used to account for the distance
between the beta decay and bremsstrahlung generation.5
Then, detailed photon transport physics in the object and
camera is included with explicit modeling of penetration and
scatter in the collimator. Because explicit modeling of all the
structures behind the crystal is not feasible, a 5-cm glass
‘backscatter layer’was used in the model.22
2.A.2. Detector response model
For the system matrix A, we computed the detector
response for primary photons only including effects of the
collimator response, penetration, and crystal scatter. Here, we
simulated (SIMIND) a point-like source in air at six distances
to the collimator (2, 5, 10, 15, 20, 25-cm) with a photon emis-
sion energy corresponding to the central energy of the acqui-
sition window. To account for the beta range effects (finite
distance between location of decay and bremsstrahlung emis-
sion), we took the approach of Elschot et al.6 and sampled
the photon emission position from within a small sphere
instead of a point. Using a high-energy (HE) collimator with
a relatively low energy acquisition window (105 to 195-keV),
the CDR was well-fitted by a Gaussian function, and did not
require modeling the penetration tails that are prominent
when using higher energy acquisition windows.23
TABLE I. Full-energy events and scatter estimate that make up the first and
second terms of the measurement model [Eq. (1)]. Attenuation in the object
and CDR are included in either the system matrix or the scatter estimate
according to the rightmost column.
Emission
(keV)
Object
scatter?
Interaction in
collimator
Last interaction
in crystal
Modeled in
system matrix or
MC scatter
estimate?
< 105a Excluded
105–195 Yes Any Any Scatter estimateb
No Scatterc Any Scatter estimateb
No Geometric or
penetration
Scatter Scatter estimateb
No Geometric or
penetration
Photoabsorptiond System matrix
(full energy evente)
> 195 Yes Any Any Scatter estimate
(downscatter)b
No Scatter Any Scatter estimate
(downscatter)b
No Geometric or
penetration
Scatter Scatter estimate
(downscatter)b
No Geometric or
penetration
Photoabsorptiond Excluded (full
energy deposited
in crystal, but >
195-keV)
aPhoton cutoff energy in SIMIND was set at 90-keV to allow for energy resolution
effects.
bIgnored if detected energy is outside 105–195-keV.
cScatter in camera components such as the backscatter layer is treated in the same
manner.
dIncludes scatter in crystal followed by photoabsorption.
eDetected energy = bremsstrahlung emission energy.
Medical Physics, 44 (12), December 2017
6366 Dewaraja et al.: 90Y SPECT/CT with Monte Carlo scatter modeling 6366
2.B. Image reconstruction with MC scatter
Our OS-EM algorithm,24 developed for conventional
SPECT reconstruction, was used here with the above
described scatter estimation and CDR model. Initial iterations
were performed without scatter (s0 = 0 in Fig. 1) but with
both attenuation and CDR modeling corresponding to the
center energy of the acquisition window. This initial recon-
struction yields an activity map estimate and together with
the CT-based density map defines the input for SIMIND to
generate the first scatter estimate. With appropriate scaling
(see below), we used this MC scatter estimate in the next sev-
eral iterations of OS-EM. This process was repeated with
subsequent updates of the SIMIND scatter estimate.
To scale the scatter estimate appropriately, we conjecture
that the unknown scatter component si is proportional to the
SIMIND scatter counts sSIMINDi and the measured counts Yi
are also proportional to the total SIMIND generated counts
YSIMINDi with the same fraction at each pixel i as follows:
si ¼ aisSIMINDi ; Yi ¼ aiYSIMINDi (2)
The SIMIND MC simulator generates the estimates
YSIMINDi , s
SIMIND
i using as input the estimated image from the
previous iteration. The fraction ai is:
ai ¼ Yi
YSIMINDi
(3)
The scatter estimate for subsequent iterations is:
si ¼ sSIMINDi
Yi
YSIMINDi
 
(4)
After scaling we smoothed the scatter sinogram using a (3
pixel FWHM) 3-D Gaussian filter to reduce noise effects.
We also investigated the global fraction model
si ¼ bsSIMINDi where b can be obtained easily by calculatingP
i Yi=
P
i Y
SIMIND
i . However, this model did not yield good
reconstruction results empirically in our simulation studies.
One possible explanation for this is that the SIMIND values
YSIMINDi , s
SIMIND
i may be underestimated together or overesti-
mated together locally. Therefore, the fraction ai may be able
to compensate for these estimation errors perhaps leading to
a better scatter estimate si.
2.C. Phantom setup
2.C.1. Line source measurement to validate SIMIND
To validate SIMIND for 90Y and our SPECT system, a line
source measurement was performed. This measurement fol-
lowed the NEMA guidelines for measuring (planar) spatial
resolution, but the source geometry was adapted to provide a
sufficient medium to generate bremsstrahlung photons.
Instead of using a line source in ‘air’, a 1 mm diameter capil-
lary tube filled with 90Y in the form of a chloride solution
(PerkinElmer) was positioned at the center of a small water
filled vial 4.0-cm long and 1.5-cm in diameter (Fig. S1). The
same phantom/camera geometry and gamma camera parame-
ters used in the measurement (see section on Image Acquisi-
tion) were used for the SIMIND model.
2.C.2. Torso phantom measurement
A torso phantom with a fillable liver and lung compart-
ments (Data Spectrum) was modified to include three intra-
hepatic ‘lesions’ (Fig. 2). The phantom compartments
3D OS-EM
AC, CDR
w/o SC
MC 
Simulation
3D OS-EM
AC, CDR 
& MC SC
x0
s0=0 sn
xn
End?
No
Yes
First Recon Recon
Measured 
Projections, Y
CT
Density 
Measured 
Projections, Y
FIG. 1. Flowchart illustrating combination of Monte Carlo scatter estimation with an analytical forward projector.
FIG. 2. The liver/lung torso phantom (left) was positioned in-between a skull and elliptical phantom for SPECT/CT imaging (right). [Color figure can be viewed
at wileyonlinelibrary.com]
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(Table II) were filled with water mixed with a chelator to
avoid adherence of 90Y to the plastic walls.25 90Y activities in
the form of a chloride solution were carefully measured on a
CRC-15 (Capintec) dose calibrator using the recommended
dial setting #55 for 90Y solutions in plastic syringes26 and
injected in to the compartments. The volume outside the liver
and lungs was filled with ‘cold’ water. The activity concen-
trations and volumes of the various phantom compartments
are given in Table II. These activity concentrations result in a
lesion-to-normal liver activity concentration ratio of ~5:1 and
a lung shunt of ~5% and were selected to mimic ratios typical
for RE.27–30 In addition, to assess visibility, three extrahepatic
objects filled with very low activity concentrations (Table II)
were positioned in the cold background to mimic inadvertent
extra-hepatic deposition of microspheres. The total activity in
the phantom was 566 MBq. To mimic events that are
detected following scattering by tissue that is outside the
camera field-of-view (FOV), a skull phantom and a uniform
elliptical phantom both filled with ‘cold’ water was placed on
either side of the liver/lung phantom (Fig. 2).
The liver concentration of 0.34 MBq/mL used in the phan-
tom was limited by radiation safety requirements of the regula-
tory authority at our institution. Therefore, to mimic counting
statistics typical in patient imaging the acquisition time was
prolonged by a factor of 2.7 (80 sec/view for the phantom
compared to 30 sec/view used in patients). The prolonged
acquisition represents a ‘simulated’ liver activity concentration
of 2.7 9 0.34 = 0.92 MBq/mL, which is clinically realistic
for patient imaging following RE with glass microspheres (see
for example the patient results discussed later).
2.D. Image acquisition and quantification
Images were acquired on a Siemens Symbia T6 SPECT/
CT equipped with a high energy general purpose collimator
(hole length 59.7 mm, hole diameter 4 mm, septa 2 mm). A
105–195-keV bremsstrahlung acquisition window was
selected (for all acquisitions in this paper) based on a prelimi-
nary simulation study investigating the primary-to-scatter
ratio.31 This range was also used in a previous study by Min-
arik et al.,4 as it avoids characteristic x-rays (below ~80-keV)
produced in the lead collimator and because the primary-to-
scatter ratio decreases at > 200-keV.
For the planar measurement with the line source, the
source was positioned 10-cm from the collimator and imaged
with a 512 9 512 matrix (pixel size 1.2-mm). A background
image for the same conditions was also acquired and sub-
tracted from the line source image. SPECT/CT was acquired
on the Siemens Symbia with the following acquisition param-
eters: 180° and 64 views per head with 80 sec/view
(phantom) and 30 sec/view (patients); body contouring; step-
and-shoot (phantom) or continuous motion (patients); and a
128 9 128 matrix with a pixel size of 4.8-mm. The CT com-
ponent of acquisition used full circle rotation, 130-kV, 80-
mAs and was reconstructed with a 512 9 512 9 196 matrix
(0.98-mm 9 0.98-mm 9 2-mm voxel size). The CT-based
attenuation map (at 150-keV) generated with the camera soft-
ware was saved and used in our reconstruction.
To quantify activity in the phantom compartments, a cali-
bration factor (CF) was computed for each reconstruction
method by dividing the liver volume-of-interest (VOI) counts
by the ‘known’ total liver activity. To convert counts to activity
the SPECT voxel counts were multiplied by this CF. The liver
relative calibration approach used here and in past dosimetry
studies29,32–35 is considered to be suitable for RE because the
infused microspheres become permanently trapped in the
micro capillaries of the treated liver and do not redistribute.
2.E. Phantom evaluation
We compared SPECT reconstruction, with and without
scatter correction, using metrics for quantification accuracy,
contrast, image noise, and visibility. For all of these metrics
VOIs corresponding to the ‘true’ anatomical boundaries were
defined on CT and applied to coregistered SPECT. The ‘nor-
mal liver’ is defined as the liver VOI minus the VOIs corre-
sponding to the three intrahepatic lesions.
Quantification for object i is evaluated by comparing the
SPECT estimated activity, Ai, with the true activity, ATruei :
Activity Recovery ¼ 100%  Ai=ATruei (5)
Contrast recovery for the hepatic lesions is calculated by:
CRi ¼ 100  Ci=CBKG  1R 1 (6)
where Ci is the mean counts for object I, CBKG is the mean
background (normal liver) counts and R is the true lesion-to-
normal liver activity concentration ratio.
Noise in the background region is calculated as:
noiseBKG ¼ 100% STDBKGCBKG (7)
TABLE II. Activity concentrations used in the torso phantom experiment.
Volume
(mL)
Activity
concentration
MBq/mLa
Target-to-
background
activity
concentration
ratio
Normal liver (liver minus
hepatic ‘lesions’)
1168 0.34
Lung 2186 0.01
Hepatic lesion 1 (sphere) 31 1.76 ~5:1
Hepatic lesion 2 (sphere) 14 1.68 ~5:1
Hepatic lesion 3 (ovoid) 28 1.63 ~5:1
Extra-hepatic object 1
(sphere)
16 0.85 ‘Cold’
background
Extra hepatic object 2
(sphere)
12 0.04 ‘Cold’
background
Extra hepatic object 3
(ovoid)
10 0.2 ‘Cold’
background
aValues need to be scaled by 92.7 to get ‘simulated’ activity concentration since
the phantom acquisition time was 2.7 times the typical acquisition time for
patients.
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where STDBKG is the standard deviation of voxel counts in
the background region. Here, background is defined as the
normal liver eroded by 1-cm to avoid edge effects and spill-
out from the lesions.
The contrast-to-noise ratio for the intrahepatic lesions and
extrahepatic objects is calculated as:
CNRi ¼ Ci  CBKGð Þ=STDBKG (8)
where, for the intrahepatic lesions, the background VOI is the
normal liver while for the extra hepatic objects the back-
ground VOI is defined by a sphere of equal volume posi-
tioned in the ‘cold’ background in the vicinity of the object.
The ability of a human observer to detect low levels of 90Y
concentration was assessed based on the Rose criterion,36
applied in the past to 90Y PET imaging evaluations.37,38 The
visibility is related to both the CNR and the size of the object
and is assessed by the detectability index:
Vi ¼ CNRi 
ffiffiffiffiffi
Ni
p
(9)
where Ni is the number of voxels in the center slice of the
object i.
2.F. Patient studies
2.F.1. Imaging and quantification
The SPECT reconstruction with MC scatter correction was
evaluated in five patients treated with 90Y RE at the University
of Michigan Medical Center for cancer involving the liver.
The routine treatment protocol for RE with glass microspheres
(Theraspheres) was followed. The administered activity for the
five patients ranged from 0.7 to 3.9 GBq while the lung shunt
fraction ranged from 3% to 6%. Approval by the University of
Michigan Internal Review Board (IRB) was obtained to access
relevant patient information and imaging data to evaluate the
current in-house developed reconstruction method. Post-ther-
apy 90Y SPECT acquisition time was 32 min and was per-
formed within 1–3 hours post RE (prior to discharge) as part
of the clinical protocol. The camera and other acquisition
parameters for SPECT/CT were as described in the phantom
study. In the 5 patients a trained Radiologist (RK) contoured a
total of 11 well-defined hepatic lesions and the treated liver
segment/lobe on baseline CT or MRI. Following coregistration
contours were applied to 90Y SPECT/CT images. As in the
phantom study, the lesion and normal liver activities were
quantified using the (liver) relative calibration factor computed
individually for each patient and each reconstruction method.
Here, the ‘true’ liver activity was set equal to the infused 90Y
activity corrected for the lung shunt fraction obtained from
planar Tc-MAA imaging.
2.F.2. Statistical analysis
The lesion and normal liver activity concentrations and the
lesion-to-normal liver uptake ratios without and with scatter
correction were compared. For the lesion level outcomes (ac-
tivity concentrations for individual lesions), the within-lesion
differences in outcome were analyzed in mixed effect models
with a fixed effect for the mean difference between the two
reconstruction methods. Patient level random intercepts were
included to account for possible between-lesion, within-patient
correlation. For the patient level outcomes (activity concentra-
tion in normal liver), a Wilcoxon signed rank test was used to
test for any differences between the two reconstruction meth-
ods. Two-sided P-values less than 0.05 were considered signif-
icant and all analyses were performed in SAS 9.4.
3. RESULTS
3.A. Comparison of simulation with measurement
Figure 3 compares the simulated and measured line pro-
files that show excellent agreement. The FWHM and FWTM
of the measured profile was 13.6 and 23.4-mm, respectively,
while that of the simulated profile was 13.7 and 24.8-mm
respectively. In addition, a SIMIND simulation correspond-
ing to the experimental phantom setup was also performed
and projections were compared with the measured projec-
tions. The profiles across the center of one of the projections
are compared in Fig. 4 and show a high level of agreement in
the distribution with some underestimation in the simulated
counts. Note that in the projection images the low intensity
‘line’ below the liver corresponds to the air gap that was pre-
sent between the liver phantom and the adjacent ‘cold’ ellipti-
cal phantom (Fig. 2), as they could not be placed directly
next to one another due to the design of the phantoms. The
contribution from scatter events in the ‘cold’ elliptical phan-
tom is evident in the projection images.
3.B. Phantom reconstructions
3.B.1. Activity recovery, contrast recovery, and
noise
The lesion contrast-to-noise ratio (averaged over the 3
liver lesions) and activity recovery for all VOIs are plotted
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FIG. 3. Profile (10-pixel wide) across the measured and simulated line
source. Profiles have been normalized to their maximum value. [Color figure
can be viewed at wileyonlinelibrary.com]
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versus iteration and as a function of scatter update in Fig. 5
(all reconstructions used 8 subsets). These curves were the
basis for selecting the number of scatter updates, the number
of OS-EM iterations per update, and the total number of iter-
ations for the results discussed in the rest of the paper. With-
out scatter correction, the CNR reaches a maximum at
around five iterations, and therefore the first MC scatter esti-
mate, MCS1, was obtained at this point. Similarly, based on
the trends of the CNR plots, further scatter updates were
made at 10 (MCS2) and 15 (MCS3) iterations. Since the
CNR and activity recovery does not change substantially after
two scatter updates, the results presented in the rest of the
paper are with MCS1 and MCS2 only. Based on the conver-
gence in activity recovery the total number of iterations was
set to 15 iterations (eight subsets).
The profiles of Fig. S2 show the pixel-level scatter frac-
tions [sSIMINDi =Y
SIMIND
i of Eq. (4)] for the same projection as
in Fig. 4. The scatter fractions ranged from around 0.6 to 0.8
for pixels corresponding to the liver region to 1.0 for pixels
corresponding to cold regions. As evident in the figure there
is good agreement between the true and estimated scatter
fractions after just two MC updates. In the cold regions out-
side the liver and outside the phantom the scatter fraction is
consistently underestimated (0.8–0.9 compared with the true
value of 1.0).
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FIG. 4. Measured and simulated projection images (at 00) of the liver
phantom and corresponding line profiles. Profiles were summed over 10 bins
centered on the center sphere. [Color figure can be viewed at wileyonlineli-
brary.com]
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FIG. 5. (a) Lesion CNR, (b) lesion activity recovery, (c) normal liver activity recovery and (d) lung activity recovery for the different reconstructions of the phan-
tom data. [Color figure can be viewed at wileyonlinelibrary.com]
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Figure 6 shows a clear improvement in contrast between
liver lesions and the normal liver as well as between the liver
and the cold background when the MC scatter estimate is
included in the reconstruction. Table III shows the quantita-
tive improvement with scatter correction. Without scatter cor-
rection the normal liver activity is overestimated and the
lesion activity is underestimated. Scatter correction substan-
tially improves activity and contrast recovery in all volumes
with only a small increase in noise. For lesions, activity
recovery improved from > 55% without scatter correction to
> 81% with a single MC scatter update and to > 86% after
two updates. In lungs, reconstruction without scatter correc-
tion leads to a large overestimation of activity (recovery
227%) and two scatter updates are needed to achieve accurate
activity recovery.
3.B.2. Visibility
Figure 7 demonstrates the qualitative improvement in
detectability with scatter correction. The visibility index is
very high for all objects except for the two extrahepatic
objects with the lowest activity concentration when no scatter
correction is used (Table IV). However, with MC scatter cor-
rection the visibility for these two objects increased substan-
tially (from 11 to 81 and from 8 to 27).
3.C. Patient studies
The reconstruction parameters selected based on the phan-
tom CNR curves were also used in the patient study (15 total
iterations with eight subsets, two scatter updates at iteration 5
and 10). Qualitatively, the increase in contrast with scatter
correction is evident in the patient images (Figs. 8 and S3).
This is especially true in the case of Fig. 8, which shows a
large necrotic lesion with an enhancing rim. In Fig. 8, in
addition to comparing the SPECT images comparison is also
made to 90Y PET, which was obtained with University of
Michigan IRB approval for the purposes of research. The
PET/CT data were acquired with a Siemens mCT scanner
and was reconstructed with Siemens 3D-OS-EM software
including point-spread function and time-of-flight informa-
tion using 1 iteration, 21 subsets, and a 5-mm FWHM Gaus-
sian postfilter. The matrix size was 200 9 200 (pixel size
4.07-mm). These PET parameters were chosen based on a
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FIG. 6. An axial slice of the true activity map and the different reconstructions w/o and with SC and the corresponding line profiles for this slice. Profiles were
summed over 30 bins centered on the center sphere. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE III. Activity recovery, contrast recovery and noise for the phantom experiment. All reconstructions used a total of 15 iterations (8 subsets).
Activity recovery (%) Contrast recovery (%)
Noise (%)Normal liver Lung 31 mL sphere 28 mL ovoid 14 mL sphere 31 mL sphere 28 mL ovoid 14 mL sphere
w/o SC 113.0 226.5 62.6 65.2 54.6 44.5 46.2 34.7 13.0
w/MCS1 105.9 130.1 81.1 91.0 81.4 70.8 82.0 70.8 15.0
w/MCS2 103.8 103.9 85.9 99.0 90.2 78.4 94.1 83.4 16.5
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previous phantom study.39 The images and profiles of Fig. 8
show better contrast and agreement with PETwhen MC scat-
ter estimation is included in the SPECT reconstruction. With-
out scatter correction the sharp drop in counts in the center
(necrotic) part of the lesion is much less pronounced.
Table V compares lesion and normal liver activity concen-
tration for the five patients estimated using the liver relative
calibration from SPECT reconstructions without and with
MC scatter estimation. For the 11 lesions, mean activity con-
centration is 4.9 (range 1.4 to 8.8) MBq/mL without scatter
correction and 7.1 (range 1.4 to 12.7) MBq/mL with scatter
correction (P = 0.0547). The mean normal liver activity con-
centration is 1.6 (range 1.1–2.2) MBq/mL without scatter cor-
rection and 1.5 (range 1.1–1.9) MBq/mL with scatter
correction (P = 0.056). The mean lesion-to-liver uptake ratio
is 2.7 (range 0.8 to 4.3) without scatter correction and 4.3
(range 1.0 to 9.1) with scatter correction (this difference was
statistically significant with P = 0.0402). The same trends
shown in Table III for the phantom study are demonstrated
here for the patients: without scatter correction lesion activi-
ties are underestimated while the normal liver activity is over-
estimated when compared with scatter corrected SPECT. The
only exceptions are the two large necrotic tumors in the liver
of patient #3. In this case, the anatomical lesions outlined on
the CT are likely not a good representation of the viable
lesions, and for this patient’s lesions the outlines were there-
fore also defined by thresholding the SPECT, guided by the
CT outline. With these functional lesion outlines, the activity
concentrations estimated by SPECT without scatter correc-
tion were lower than those estimated with scatter correction
(3.7 vs. 4.4 MBq/mL for lesion 1 and 3.2 vs. 3.7 MBq/mL
for lesion 2).
3.D. Photon histories and simulation times
The MC scatter estimates for the phantom and patient
studies discussed above were generated with 500 million pho-
ton histories per projection with a total simulation time of
approximately 8 hours on a 12-core (2.7 GHz) Mac-pro per-
sonal computer. The effect of using fewer photon histories
was investigated to determine the potential for reducing the
simulation time. Reconstructions of the data for the phantom
and for patient #3 were repeated with the scatter estimates
generated using 50 and 5 million photons per projection, cor-
responding to simulation times of around 40 and 4 min
respectively. Comparison of profiles across the reconstructed
images show that results for 50 million photon histories are
almost identical to those for 500 million photon histories,
while visible differences are seen at 5 million histories
(Fig. S4). The difference between total lesion counts for the
500 million history case is < 1.4% when histories are reduced
to 50 million but up to 7.8% when histories are reduced to
five million. Comparison of reconstructions corresponding to
four realizations (with 4 different random seeds) of the 50
million case showed the difference between realizations to be
< 0.8% for total lesion counts.
4. DISCUSSION
Model-based methods are necessary for scatter correction
in 90Y SPECT because energy window-based methods are
not feasible with the continuous bremsstrahlung energy spec-
trum. In the present study we implemented and validated a
Monte Carlo based scatter estimation method, where the scat-
ter estimate is combined with an analytical projector.
The high level of agreement between 90Y measurement
and SIMIND shown here for our SPECT/CT system has been
demonstrated before for other systems.5 The slight underesti-
mation in the tails of the line source profile (Fig. 3) is poten-
tially due to photon scattering by the second camera head or
surrounding objects not included in the camera model. In the
phantom experiment there is further underestimation of
counts (Fig. 4) because the phantom extended beyond the
FOV, but the activity estimate and density map used as input
to SIMIND are only available for the FOV as in patient imag-
ing. Unlike a fully MC based reconstruction, our approach is
not highly sensitive to small differences between measure-
ment and simulation because MC is used only to generate the
scatter fraction. The present phantom study mimicked the
clinically realistic situation for RE where there is high uptake
in the liver and low uptake in lungs surrounded by a cold
FIG. 7. Coronal SPECT/CT slices without (top row) and with (bottom row)
scatter correction, demonstrating visibility of the hepatic lesions (left) and
the extra hepatic objects (right). [Color figure can be viewed at wileyonlineli-
brary.com]
TABLE IV. Visibility for the hepatic lesions in ‘warm’ background and extra
hepatic objects in ‘cold’ background.
Volume (mL)
Visibility
w/o SC w/MCS1 w/MCS2
Intrahepatic 31 mL sphere 79.3 105.4 105.3
Intrahepatic 28 mL ovoid 57.4 86.0 89.2
Intrahepatic 14 mL sphere 43.8 76.6 81.8
Extrahepatic 16 mL sphere 166.4 520.7 671.7
Extrahepatic 10 mL ovoid 11.1 58.2 81.0
Extrahepatic 12 mL sphere 8.0 22.3 26.5
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background. This is a more challenging condition in terms of
scatter than past 90Y imaging evaluations that have typically
relied on geometries consisting of hot spheres in a uniform
background.6,8,37,38
Our interest is in accurate quantification of lesion and nor-
mal liver activity for estimating mean absorbed dose as well
as 3-D activity distributions for radiobiological dosimetry,40
where low noise is of importance. Here, we show significant
improvement in contrast recovery and activity recovery with
MC scatter estimation with only a small degradation in noise
(13% to 17% in Table III). Without scatter correction there is
poor contrast, which translates to a significant underestima-
tion of intrahepatic lesion activity and overestimation of the
normal liver activity. For the normal liver, the overestimation
in activity recovery went from 113% without scatter correc-
tion to 106% with a single update and 104% with two
updates. For the smallest liver lesion, activity recovery
improved from 55% without scatter correction to 81% with a
single update of the scatter estimate and 90% with two
updates. The lesion activity recoveries of the present study
are somewhat higher than expected for SPECT imaging with
a high-energy collimator, even with CDR modeling. This is
attributed to the liver relative calibration used to quantify
lesion activities and to imperfect scatter correction. If scatter
is underestimated in the lesions relative to the liver some of
the count loss due to partial volume effects is ‘compensated’
by uncorrected scatter counts.
Although lung-shunt calculations are performed prether-
apy with a Tc-MAA planning study, here we also investigated
the accuracy in estimating the lung activity with 90Y SPECT/
CT, as this enables post-therapy verification of the delivered
dose to the lung to evaluate potential toxicity. For the lung
region where activity concentration is low, scatter is a much
higher component of the total counts than in the liver, and
FIG. 8. For patient #3 the SPECT reconstruction without and with scatter correction is compared with 90Y PET. Profiles are across the center of the large necrotic
lesion contoured on the catheter directed selective hepatic arterial contrast enhanced CT. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE V. Patient lesion and normal liver activity concentrations estimated
from SPECTwithout and with scatter correction.
Patient # Diagnosis Volume (mL)
SPECT estimated
concentration
(MBq/mL)
w/o SC With SC
1 Liver mets
(NETa)
Lesion 1 68.6 6.3 8.0
Lesion 2 7.1 6.7 10.9
Lesion 3 7.5 5.2 7.3
Lesion 4 32.3 8.8 12.3
Lesion 5 6.1 6.8 9.1
Normal liver 1168 2.2 1.9
2 HCCb Lesion 1 40.2 2.7 4.3
Lesion 2 6.2 6.5 12.7
Normal liver 1502 1.5 1.4
3 Liver mets
(NET)
Lesion 1 820.3 1.6 1.6
Lesion 2 523.4 1.4 1.4
Normal liver 472 1.7 1.4
4 HCC Lesion 1 27.3 3.7 4.3
Normal liver 388 1.7 1.6
5 Liver mets
(NET)
Lesion 1 17.2 4.2 6.1
Normal liver 717.8 1.1 1.1
aNET, neuroendocrine tumor.
bHCC, hepatocellular carcinoma.
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scatter modeling is even more challenging. In the present
study, activity overestimation in the lung was as high as
226% without scatter correction and two updates of the scat-
ter estimate were needed to achieve accurate activity recovery.
The substantial improvement in the visibility index with scat-
ter correction (Table IV) is particularly significant in the case
of the extrahepatic objects in cold background due to safety
concerns associated with unexpected microsphere deposition
outside the liver. According to the Rose criteria an object is
discernible when the visibility index is > 536; however, as dis-
cussed in recent studies37,38 this threshold depends on the
size and shape of the lesion. When assessing 90Y PET acqui-
sition protocols Carlier et al.38 used a limit of > 8 for objects
that are approximately circular in shape. In the present study,
without scatter correction the visibility index was below this
cutoff for the object with the lowest activity concentration,
but well-exceeded this limit with scatter correction.
Our patient images and results re-enforces the trends
observed with the phantom data. Without scatter correction
patient lesion activity concentrations and the lesion-to-liver
uptake ratios are substantially underestimated and liver activ-
ity concentration overestimated when compared to scatter
corrected SPECT (Table V). These differences will translate
to similar differences in absorbed dose estimation. With just
1–2 updates of the scatter estimate there was visible increase
in contrast in the liver lesions (Figs. 8 and S3). For one
patient with large necrotic lesions the SPECT images were
compared with 90Y PET and the reconstruction with scatter
correction showed better agreement with PET, which can be
considered as the gold standard here. Given the lack of uptake
in the center of the tumor accurate imaging can potentially
determine which tumors may require boosts with external
radiation therapies such as SBRT. The activity concentrations
and lesion-to-liver uptake ratios of the present patient study
can be compared with limited previous studies where these
values were reported for RE with glass microspheres. Based
on pretherapy Tc-MAA imaging Garin et al. reported29
lesion-to-liver ratios of 0.6 to 25.9 (mean 7.2) for patients
with HCC. Based on post-therapy 90Y SPECT using standard
reconstruction without scatter correction, Kokabi et al.
reported32 lesion concentrations of 0.7–7.4 MBq/mL (mean
2.9) for patients with HCC.
Although our MC scatter estimate was used in a single-
window acquisition/reconstruction approach here, it can be
extended to a multiwindow approach, which will be the focus
of a future study. The single window approach simplifies the
reconstruction process as it allows the use of an attenuation
map and CDR determined at a single energy. For this single-
energy we used the center energy of the window while
others41 have used the mean energy of the window as it
accounts for the energy dependence of the bremsstrahlung
yield. However, that alternative would not significantly
impact our results as the center energy and the mean energy
in tissue are very close for the energy range considered
here (150-keV vs. 142-keV). For the 105–195-keV range
of the present study, the attenuation coefficient in tissue at
the center energy is within 15% of the value at the lower
and upper energy bounds of the window.42 Phantom and
patient results of the present study demonstrates that the
count-rate with the relatively narrow window is sufficient
for imaging following RE where there is high focal activ-
ity in the liver.
Limitations of the present study are that the phantom study
evaluated relatively large (> 14 mL) lesions only and a single
lesion-to-liver activity concentration ratio of 5:1. Although
these values are typical for RE, there is a large range in lesion
size and uptake ratios and these are well worth investigating
in a future study. In addition, the quantification approach of
the present study was limited to the relative calibration
approach based on the assumption that the activity in the liver
is known.29,32–35 This has the advantage that a separate acqui-
sition of a calibration phantom or source with known activity
is not required to determine a CF that relates detected counts
to activity. However, this approach is inadequate if the inad-
vertent deposition of microspheres outside the liver is signifi-
cant or if the lung shut fraction is relatively large and
substantially different from the pretherapy estimation. In a
future study the relative calibration approach will be com-
pared with that using an external CF, which should ideally be
determined with a phantom geometry that approximates the
patient, such as the liver/lung phantom of the present study.
An advantage of a fully MC based reconstruction is that with
a well-validated MC code quantitative results can be obtained
without the need for a calibration measurement. However,
our approach puts less demand on computational require-
ments than a fully MC approach. The present work demon-
strated that accurate reconstruction can be achieved with just
two scatter updates and with 50 million photon histories/per
projection with a simulation time of around 40 min on a per-
sonal computer. Keeping the scatter component separate also
facilitates combining our approach with commercial recon-
struction software designed for conventional SPECT. It is fea-
sible that the window-based scatter estimates typically
available with commercial software can be replaced by a MC
generated scatter estimate.
5. CONCLUSION
A 90Y bremsstrahlung SPECT reconstruction approach
with MC based scatter estimation was implemented and evalu-
ated. The relatively narrow single window used here for both
the acquisition and projector modeling was shown to be suffi-
cient for the RE application where there is high focal liver
uptake, but may be inadequate for other applications with low
count-rates. Phantom experiments showed substantial
improvement in contrast and activity recovery without signifi-
cant increase in noise with just two updates of the scatter esti-
mate. Patient studies confirmed the trends observed in the
phantom study with substantial underestimation of lesion
activity concentration and lesion-to-liver uptake ratio without
scatter correction compared with reconstruction with two
updates of the MC scatter estimate. Evaluation of the required
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number of photon histories showed that MC simulation time
can be reduced by a factor of 10 without compromising results,
which is promising for clinical implementation.
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Fig. S1. 90Y line source positioned at the center of a 4.0 cm
long 1.5 cm diameter water filled vial.
Fig. S2. Profiles across the ‘true’ and estimated scatter frac-
tions (sSIMINDi =Y
SIMIND
i ) for the same projection as in Fig. 4.
The ‘true’ scatter fractions correspond to MC simulation of
the true activity map, while the estimated scatter fractions
correspond to MC simulation of the SPECT measured activ-
ity map. Profiles were summed over 10 bins centered on the
center sphere. The phantom extends from pixel 25 to 105 and
the liver from pixel 38 to 84.
Fig. S3. Axial slice of the baseline CT and SPECT/CT with-
out and with scatter correction for patient #4. The lesion con-
tour defined on baseline CT is applied to coregistered
SPECT/CT.
Fig. S4. Profiles across the phantom image of Fig. 6 (left)
and patient image of Fig. 8 (right) as a function of the num-
ber of photon histories (per projection) used to generate the
MC scatter estimate.
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